SOPHOMER
LIVE

Serial Number

79370561

Owner

ELISA development, s.r.o.

Attorney

John Zaccaria

Filing Date

Dec 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SOPHOMER Trademark

Serial Number: 79370561 • Registration: 7435617

SOPHOMER is a trademark filed by ELISA development, s.r.o. on December 2, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ELISA development, s.r.o.

Velké Zernoseky 186

Entity Type: 16

Ústav makromolekulární chemie AV CR, v.v.i.

Heyrovského nám. 2

Entity Type: 99

Sophomer s.r.o.

Radiová 1285/7,

Entity Type: 16

i&i Prague, s.r.o.

Flemingovo námestí 542/2

Entity Type: 16

Trademark Details

Filing Date

December 2, 2022

Registration Date

July 9, 2024

Published for Opposition

April 23, 2024

Goods & Services

Chemical analysis; life science research and development services; scientific research for medical purposes; pharmaceutical research; biological analysis; analytical medical laboratory services; analysis in the field of molecular biology; biochemistry research services; laboratory testing and contract assay development chemistry services; chemical research and analysis services; biological research; biological laboratory services; pharmaceutical, medical and dental laboratory services, namely, laboratory testing; design and development of medical diagnostic apparatus; [ medical consultancy in the fields of laboratory research, testing, measuring, and analysis; medical consultancy in the field of design and development of medical equipment; ] consultancy in the fields of medical measuring, testing and analysis; design and development of computer hardware and software for healthcare requirements; computer programming in the medical field; providing information on the subject of scientific research in the field of biochemistry and biotechnology; [ science and technology services, namely scientific research, analysis and testing in the fields of biochemistry and biotechnology; ] technological consultancy in the fields of biochemistry and biotechnology; [ scientific and ] technological services, namely, computer aided testing for others in the fields of biochemistry and biotechnology; [ medical laboratory services; ] none of the foregoing relating to the field of security or cybersecurity hardware, software or services

[ Chemical substances and chemical preparations for scientific purposes, other than for medical or veterinary use; ] chemical substances for analysis in laboratories, other than for medical or veterinary purposes; chemical compositions for use in science, other than for medical or veterinary use; chemicals for use in separation techniques, other than medical or veterinary, namely, oil separating chemicals; catalysts for chemical and biochemical processes; chemical reagents, other than for medical or veterinary purposes; industrial chemicals; particulate material for use in chromatographic processes other than for medical use, namely, chromatography separation media for separation of a mixture into components; diagnostic chemicals other than for medical or veterinary use; diagnostic preparations for scientific or research use; unprocessed synthetic polymers; diagnostic testing materials in the nature of paramagnetic particles, separation membranes, reagent bearing test strips, cell culture media supplements and reagents, other than for medical use; reagents for use in analytical tests, other than for medical or veterinary purposes; unprocessed polymers for use in the analysis of biochemicals; chemicals for use in immuno-assay testing, other than medical or veterinary use; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria, other than for medical or veterinary purposes

Medical apparatus and instruments, namely, multiwell plates, point of care instruments and in vitro diagnostics analyzers; medical apparatus for use in cellular analysis and diagnosis for testing of cellular biomarkers in blood, urine, body fluids, in vitro cultured cells; diagnostic apparatus for medical purposes for testing of biomarkers in blood, urine, and body fluids, cells and tissues; testing apparatus for medical purposes for testing of biomarkers in blood, urine, body fluids, cells and tissues; [ robotics for medical purposes, namely, surgical robots; ] medical apparatus for measuring and displaying data measured from bodily fluids, including accessories in the nature of tubes and systems for body fluids storage; blood testing apparatus; medical apparatus for measuring biochemical changes in the blood; tools for sample preparation for medical diagnostics testing

Medical diagnostic services; medical services for the analysis of samples taken from patients for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Chemical test reagents for medical purposes; chemical reagents for medical use; diagnostic substances for medical use; diagnostic chemical reagents for medical use; chemical preparations for medical purposes, namely, for blocking of nonspecific interactions in the diagnostic assays; chemical substances for use in separation for medical and veterinary purposes; chemicals for use in chromatography for medical and veterinary purposes, namely, chromatography separation media for separation of a mixture into components; diagnostic testing materials in the nature of paramagnetic particles, separation membranes, medical diagnostic test stripsand reagents for medical use for blood, urine, and body fluids testing; in vitro diagnostic preparations for medical use; reagents for in-vitro laboratory use for medical purposes; immunoassay reagents for medical use; diagnostic preparations for medical purposes

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Mar 4, 2026 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 16, 2025 INPR
CHANGE OF OWNER RECEIVED FROM IB
May 23, 2025 CHLD
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Feb 4, 2025 NURC
LIMITATION FROM THE IB EXAMINED AND ENTERED
Jan 17, 2025 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Jan 16, 2025 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 16, 2025 APRE
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 9, 2024 FICR
LIMITATION OF GOODS RECEIVED FROM IB
Sep 20, 2024 LIMG
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Apr 30, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 10, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 3, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 27, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 27, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 27, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 27, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 27, 2024 COAR
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 3, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 3, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 21, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 20, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 30, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 25, 2023 REPR